Using Ultrasound to Analyze Malignant and Benign Orbital Space-Occupying Lesions Posts

Using Ultrasound to Analyze Malignant and Benign Orbital Space-Occupying Lesions Most orbital space-occupying lesions come from tissues in the orbital space or metastasize from other system tumors. The bulk of clinical manifestations of these lesions such as diplopia, protrusion, and loss of vision are often nonspecific, so imaging technology is crucial

Risk Factors for Ocular Metastases in Invasive Ductal Carcinoma Posts

Risk Factors for Ocular Metastases in Invasive Ductal Carcinoma Invasive ductal carcinoma (IDC), also known as infiltrating ductal carcinoma, is the most common type of breast cancer, accounting for about 72% of all cases. IDC can occur at any age, but many people are over the age of 55 at the

Myelofibrosis-Biology, Management, and Case Report of Ocular Manifestation Posts

MF-BIOLOGY, MANAGEMENT, AND CASE REPORT OF OCULAR MANIFESTATION Myelofibrosis is an uncommon myeloproliferative neoplasm, a type of blood cancer where excess red blood cells, white blood cells, or platelets are produced in the bone marrow.  The rarity of this abnormality has many medical professionals struggling to understand its genetic underpinnings. This

Malignancy in Myelofibrosis Patients Receiving Ruxolitinib Therapy Posts

A Restrospective Study of Secondary Malignancies in Myelofibrosis Patients Receiving Ruxolitinib Therapy Myelofibrosis (MF) is a chronic, rare, and often fatal type of blood cancer characterized by a progressive replacement of bone marrow with fibrous scar tissue. This type of myeloproliferative neoplasm (MPN) leads to progressive spleen enlargement, systemic symptoms such

Study on the Ocular involvement in metastatic and systemic malignancies Posts

Ocular Involvement of Systemic Malignancies Systemic malignancies affecting the eye often involve the choroid or the orbital area of the eye, leading to different ocular manifestations. Ocular malignancies are relatively rare compared to malignancies of other parts of the human body. The American Cancer Society estimates there will be about 3,300 new eye cancer

Genetic Mutations for Predicting Pancreatic Ductal Adenocarcinoma Susceptibility Posts

Genetic Mutations for Predicting Pancreatic Ductal Adenocarcinoma Susceptibility Pancreatic ductal adenocarcinoma (PDAC) is the deadliest malignancy representing about 90% of all pancreatic cancers. PDAC progresses asymptomatically until death and is refractory to most treatment methods. Surgery is the most effective treatment. Nevertheless, it is well known that only 15-20% of PDAC

Using Nanofiber Antibiotic Sutures Prevent Ophthalmic Infections Posts

Using Nanofiber Antibiotic Sutures to Prevent Ophthalmic Infections Sutures are medical devices applied on the site of injury or surgery. Sutures prevent infection, minimize scarring, and fasten recovery. As of today, the only drug-eluting sutures available for antibacterial application in most surgeries are coated with triclosan. It’s known that putting drugs

Vitamin A - National Library of Medicine MedlinePlus

Vitamins are substances that your body needs to grow and develop normally. Vitamin A plays a role in your Vision Bone growth Reproduction Cell functions Immune ...

Botox - National Library of Medicine MedlinePlus

Botox is a drug made from a toxin produced by the bacterium Clostridium botulinum. It's the same toxin that causes a life-threatening type of food poisoning called botulism. ...

Exploring Gene Profiles in Small Bowel Adenocarcinoma Posts

Exploring Gene Profiles in Small Bowel Adenocarcinoma Small bowel adenocarcinoma (SBA) is one of the rarest tumors found in patients. In fact, SBA only represents about 1-3% of all gastrointestinal malignancies. Due to its rarity, genomic analyses and prognostic biomarkers are limited. About 55-82% of small bowel adenocarcinomas can be found in

Using Ultrasound to Analyze Malignant and Benign Orbital Space-Occupying Lesions